India
· Delayed Price · Currency is INR SPARC Statistics
Total Valuation
Sun Pharma Advanced Research Company has a market cap or net worth of INR 66.90 billion. The enterprise value is 65.94 billion.
| Market Cap | 66.90B |
| Enterprise Value | 65.94B |
Important Dates
The next estimated earnings date is Monday, November 4, 2024.
| Earnings Date | Nov 4, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
Sun Pharma Advanced Research Company has 324.52 million shares outstanding. The number of shares has increased by 8.93% in one year.
| Shares Outstanding | 324.52M |
| Shares Change (YoY) | +8.93% |
| Shares Change (QoQ) | -0.16% |
| Owned by Insiders (%) | 25.64% |
| Owned by Institutions (%) | 5.93% |
| Float | 91.74M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 97.77 |
| PB Ratio | 53.20 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -17.00 |
| EV / Sales | 96.39 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
| Current Ratio | n/a |
| Quick Ratio | n/a |
| Debt / Equity | 0.49 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -273.23 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | n/a |
| Return on Capital (ROIC) | -70.41% |
| Revenue Per Employee | 1.67M |
| Profits Per Employee | -9.48M |
| Employee Count | 409 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -11.19% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | -11.19% |
| 50-Day Moving Average | 218.91 |
| 200-Day Moving Average | 281.67 |
| Relative Strength Index (RSI) | 36.88 |
| Average Volume (20 Days) | 448,741 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Sun Pharma Advanced Research Company had revenue of INR 684.05 million and -3.88 billion in losses. Loss per share was -11.95.
| Revenue | 684.05M |
| Gross Profit | 326.07M |
| Operating Income | -4.03B |
| Pretax Income | -3.87B |
| Net Income | -3.88B |
| EBITDA | -3.93B |
| EBIT | -4.03B |
| Loss Per Share | -11.95 |
Balance Sheet
The company has 1.57 billion in cash and 611.51 million in debt, giving a net cash position of 959.80 million or 2.96 per share.
| Cash & Cash Equivalents | 1.57B |
| Total Debt | 611.51M |
| Net Cash | 959.80M |
| Net Cash Per Share | 2.96 |
| Equity (Book Value) | 1.26B |
| Book Value Per Share | 3.88 |
| Working Capital | n/a |
Cash Flow
| Operating Cash Flow | n/a |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
| Gross Margin | 47.67% |
| Operating Margin | -589.03% |
| Pretax Margin | -565.72% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
Sun Pharma Advanced Research Company does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -8.93% |
| Shareholder Yield | -8.93% |
| Earnings Yield | -5.80% |
| FCF Yield | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | n/a |